Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000296065 | SCV000342137 | uncertain significance | not provided | 2016-06-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001080721 | SCV001042061 | likely benign | Schimke immuno-osseous dysplasia | 2025-01-14 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001080721 | SCV002076325 | likely benign | Schimke immuno-osseous dysplasia | 2019-11-11 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003940048 | SCV004747209 | likely benign | SMARCAL1-related disorder | 2019-05-20 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |